17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details


臨床試験数 : 119 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05732415
(ClinicalTrials.gov)
March 1, 20238/2/2023Biomarker Study of ATH434 in Participants With MSAAn Open-Label Biomarker Study of ATH434 in Multiple System AtrophyMultiple System AtrophyDrug: ATH434Alterity TherapeuticsNULLNot yet recruiting30 Years75 YearsAll15Phase 2United States
2NCT05109091
(ClinicalTrials.gov)
July 1, 202222/10/2021Study of ATH434 in Participants With Multiple System AtrophyA Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple System AtrophyMultiple System AtrophyDrug: ATH434 dose level 1;Drug: ATH434 dose level 2;Drug: PlaceboAlterity TherapeuticsNULLRecruiting30 Years75 YearsAll60Phase 2United States;Australia;Italy;New Zealand;United Kingdom